|
|
Last Modified: 10/16/2007  First Published: 8/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MSKCC-98014 NCI-G98-1445, NCT00003367
|
|
|
|
|
|
|
|
Last Modified: 9/3/2008  First Published: 6/23/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
CAN-NCIC-PRP1 NCT00064194, PRP1
|
|
|
|
|
|
|
|
Last Modified: 6/1/1998  First Published: 11/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18-35
|
|
|
|
NCI
|
|
|
|
UMN-9509M10234 NCI-P97-0108
|
|
|
|
|
|
|
|
Last Modified: 12/29/2008  First Published: 3/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
Postmenopausal (20 and over)
|
|
|
|
NCI
|
|
|
|
CALGB-79805 NCI-P02-0206, NCT00031720
|
|
|
|
|
|
|
|
Last Modified: 4/29/2008  First Published: 3/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
50 and over
|
|
|
|
NCI
|
|
|
|
CALGB-79806 NCI-P02-0207, NCT00031746
|
|
|
|
|
|
|
|
Last Modified: 8/23/2008  First Published: 10/14/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
WSU-D-2325 NCT00243048
|
|
|
|
|
|
|
|
Last Modified: 5/28/2008  First Published: 6/22/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Closed
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
CCCWFU-98203 CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
|
|
|
|
|
|
|
|
Last Modified: 5/1/2001  First Published: 8/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Prevention, Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCI-98-C-0099B
|
|
|
|
|
|
|
|
Last Modified: 10/15/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
UCLA-HSPC-9508339 NCI-V96-0940
|
|
|
|
|
|
|
|
Last Modified: 10/15/2007  First Published: 5/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MCC-0104 NCI-5348, NCI-P02-0214, NCT00036686
|
|
|
|